Tag: Pharma Market Access
Pharma Market Access 2025: HTA, U.S. Drug Pricing, and Tariffs
Global Pharma Market Access Under Pressure Pharma market access is no longer just a regulatory hurdle, it’s a geopolitical challenge. With the EU’s new HTA regulation, U.S. pricing reforms, potential Trump tariffs, and legislative shifts in key markets, pharmaceutical access is facing cross-border disruption. Manufacturers must realign their strategies to sustain revenue and reach patients.…
The Future of Pharma
The Future of Pharma: How Real-World Evidence & AI Are Shaping Market Access in 2025 Why 2025 Is the Breakthrough Year for Real-World Evidence (RWE)? In 2025, AI-driven healthcare and real-world data (RWD) are transforming how treatments are evaluated, approved, and accessed across global markets. Traditional clinical trials are no longer enough. Pharma companies are…
